WOT Q1 2026: Slight Revenue Decline, EUV Qualification and Strong Financials

Consolidated Q1 2026 revenue 4.33B KRW (down 5.8% YoY from 4.60B), operating profit 0.96B, net income 1.06B (down 18.5% from 1.30B)
Completed EUV process THC evaluation and secured orders in Q1 2026; expanding into advanced nodes (HBM, Hybrid Bonder)
Chinese subsidiary turned profitable (net income 6.7M KRW)
Healthy financials: cash 4.13B, short-term financial products 52.6B, no debt, equity 67.1B (debt ratio 3.5%)
Paid cash dividend of 806M KRW (50 won per share) for FY2025
No material litigation or contingent liabilities